Subjective cognitive decline and risk of MCI The Mayo Clinic Study of Aging

被引:187
|
作者
van Harten, Argonde C. [1 ,2 ]
Mielke, Michelle M. [3 ,4 ]
Swenson-Dravis, Dana M. [4 ]
Hagen, Clinton E. [3 ]
Edwards, Kelly K. [3 ]
Roberts, Rosebud O. [3 ]
Geda, Yonas E. [3 ,5 ,6 ,7 ]
Knopman, David S. [2 ]
Petersen, Ronald C. [2 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands
[2] Mayo Clin, Dept Neurol, Behav Neurol, Rochester, MN 14625 USA
[3] Mayo Clin, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN USA
[4] Mayo Clin, Dept Neurol, Rochester, MN USA
[5] Mayo Clin, Translat Neurosci & Aging Program, Scottsdale, AZ USA
[6] Mayo Clin, Dept Psychiat & Psychol, Scottsdale, AZ USA
[7] Mayo Clin, Dept Neurol, Scottsdale, AZ USA
关键词
PRECLINICAL ALZHEIMERS-DISEASE; MEMORY COMPLAINTS; OLDER-ADULTS; SYDNEY MEMORY; AMYLOID-BETA; IMPAIRMENT; DEMENTIA; SELF; METAANALYSIS; ASSOCIATION;
D O I
10.1212/WNL.0000000000005863
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective We investigated different dimensions of subjective cognitive decline (SCD) to determine which was the best prognostic risk factor for incident mild cognitive impairment (MCI) among cognitively unimpaired participants. Methods We included 1,167 cognitively unimpaired participants, aged 70 to 95 years, from the Mayo Clinic Study of Aging based on 2 concurrent SCD scales (part of the Blessed memory test and the 39-item Everyday Cognition [ECog] scale, which included a validated 12-item derivative) and a single question assessing worry about cognitive decline. We evaluated multiple ways to dichotomize scores. In continuous models, we compared average scores on 4 ECog domains and multidomain (39- and 12-item) ECog scores. Cox proportional hazards models were used to assess the association between each measure and risk of MCI in models adjusted for objective memory performance, depression, anxiety, sex, APOE epsilon 4 carriership, and medical comorbidities. Results It was possible to select a substantial group of participants (14%) at increased risk of incident MCI based on combined baseline endorsement of any consistent SCD on the ECog (any item scored >= 3; 12-item ECog hazard ratio [HR] 2.17 [95% confidence interval 1.51-3.13]) and worry (HR 1.79 [1.24-2.58]) in an adjusted model combining these dimensions. In continuous models, all ECog domains and the multidomain scores were associated with risk of MCI with a small advantage for multidomain SCD (12-item ECog HR 2.13 [1.36-3.35] per point increase in average score). Information provided by the informant performed comparable to selfperceived SCD. Conclusion Prognostic value of SCD for incident MCI improves when both consistency of SCD and associated worry are evaluated.
引用
收藏
页码:E300 / E312
页数:13
相关论文
共 50 条
  • [1] Comparison of Gait Parameters for Predicting Cognitive Decline: The Mayo Clinic Study of Aging
    Savica, Rodolfo
    Wennberg, Alexandra M. V.
    Hagen, Clinton
    Edwards, Kelly
    Roberts, Rosebud O.
    Hollman, John H.
    Knopman, David S.
    Boeve, Bradley F.
    Machulda, Mary M.
    Petersen, Ronald C.
    Mielke, Michelle M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (02) : 559 - 567
  • [2] Decline in Weight and Incident Mild Cognitive Impairment Mayo Clinic Study of Aging
    Alhurani, Rabe E.
    Vassilaki, Maria
    Aakre, Jeremiah A.
    Mielke, Michelle M.
    Kremers, Walter K.
    Machulda, Mary M.
    Geda, Yonas E.
    Knopman, David S.
    Peterson, Ronald C.
    Roberts, Rosebud O.
    [J]. JAMA NEUROLOGY, 2016, 73 (04) : 439 - 446
  • [3] Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging
    Pankratz, V. Shane
    Roberts, Rosebud O.
    Mielke, Michelle M.
    Knopman, David S.
    Jack, Clifford R., Jr.
    Geda, Yonas E.
    Rocca, Walter A.
    Petersen, Ronald C.
    [J]. NEUROLOGY, 2015, 84 (14) : 1433 - 1442
  • [4] Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging
    Mielke, Michelle M.
    Hagen, Clinton E.
    Wennberg, Alexandra M. V.
    Airey, David C.
    Savica, Rodolfo
    Knopman, David S.
    Machulda, Mary M.
    Roberts, Rosebud O.
    Jack, Clifford R., Jr.
    Petersen, Ronald C.
    Dage, Jeffrey L.
    [J]. JAMA NEUROLOGY, 2017, 74 (09) : 1073 - 1080
  • [5] Associations between cerebrospinal fluid total phosphatidylcholines, neurodegeneration, cognitive decline, and risk of mild cognitive impairment in the Mayo Clinic Study of Aging
    Li, Danni
    Hagen, Clinton
    Bui, Hai H.
    Knopman, David
    Jack, Clifford R.
    Machulda, Mary
    Petersen, Ronald C.
    Mielke, Michelle M.
    [J]. NEUROBIOLOGY OF AGING, 2020, 93 : 52 - 54
  • [6] The incidence of MCI differs by subtype and is higher in men The Mayo Clinic Study of Aging
    Roberts, R. O.
    Geda, Y. E.
    Knopman, D. S.
    Cha, R. H.
    Pankratz, V. S.
    Boeve, B. F.
    Tangalos, E. G.
    Ivnik, R. J.
    Rocca, W. A.
    Petersen, R. C.
    [J]. NEUROLOGY, 2012, 78 (05) : 342 - 351
  • [7] Polyunsaturated Fatty Acids and Reduced Odds of MCI: The Mayo Clinic Study of Aging
    Roberts, Rosebud O.
    Cerhan, James R.
    Geda, Yonas E.
    Knopman, David S.
    Cha, Ruth H.
    Christianson, Teresa J. H.
    Pankratz, V. Shane
    Ivnik, Robert J.
    O'Connor, Helen M.
    Petersen, Ronald C.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (03) : 853 - 865
  • [8] Cortical atrophy patterns of incident MCI subtypes in the Mayo Clinic Study of Aging
    Machulda, Mary M.
    Lundt, Emily S.
    Albertson, Sabrina M.
    Spychalla, Anthony J.
    Schwarz, Christopher G.
    Mielke, Michelle M.
    Jack, Clifford R., Jr.
    Kremers, Walter K.
    Vemuri, Prashanthi
    Knopman, David S.
    Jones, David T.
    Bondi, Mark W.
    Petersen, Ronald C.
    [J]. ALZHEIMERS & DEMENTIA, 2020, 16 (07) : 1013 - 1022
  • [9] HIGH BURDEN OF COMORBIDITY INCREASES RISK OF COGNITIVE IMPAIRMENT: THE MAYO CLINIC STUDY OF AGING
    Roberts, R. O.
    Geda, Y. E.
    Knopman, D. S.
    Cha, R. H.
    Boeve, B. F.
    Rocca, W. A.
    Petersen, R. C.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S245 - S245
  • [10] Interactions Between Neuropsychiatric Symptoms and Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline: The Mayo Clinic Study of Aging
    Krell-Roesch, Janina
    Syrjanen, Jeremy A.
    Christenson, Luke R.
    Petersen, Ronald C.
    Vassilaki, Maria
    Geda, Yonas E.
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 33 (03) : 248 - 248